{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:59:19Z","timestamp":1790233159624,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adenovirus based vectors are of increasing importance for wide ranging therapeutic applications. As vaccines, vectors derived from human adenovirus species D serotypes 26 and 48 (HAdV-D26\/48) are demonstrating promising efficacy as protective platforms against infectious diseases. Significant clinical progress has been made, yet definitive studies underpinning mechanisms of entry, infection, and receptor usage are currently lacking. Here, we perform structural and biological analysis of the receptor binding fiber-knob protein of HAdV-D26\/48, reporting crystal structures, and modelling putative interactions with two previously suggested attachment receptors, CD46 and Coxsackie and Adenovirus Receptor (CAR). We provide evidence of a low affinity interaction with CAR, with modelling suggesting affinity is attenuated through extended, semi-flexible loop structures, providing steric hindrance. Conversely, in silico and in vitro experiments are unable to provide evidence of interaction between HAdV-D26\/48 fiber-knob with CD46, or with Desmoglein 2. Our findings provide insight into the cell-virus interactions of HAdV-D26\/48, with important implications for the design and engineering of optimised Ad-based therapeutics.<\/jats:p>","DOI":"10.1038\/s41467-019-08599-y","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T06:03:38Z","timestamp":1550124218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions"],"prefix":"10.1038","volume":"10","author":[{"given":"Alexander T.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Greenshields-Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-6560","authenticated-orcid":false,"given":"Lynda","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanni","family":"Uusi-Kerttula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre J.","family":"Rizkallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9302-1761","authenticated-orcid":false,"given":"Alan L.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"8599_CR1","unstructured":"Combination Adenovirus+Pembrolizumab to Trigger Immune Virus Effects\u2014Full Text View\u2014ClinicalTrials.gov. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02798406?term=adenovirus&recrs=a&cond=Glioblastoma&rank=2 (accessed 23rd September 2017)."},{"key":"8599_CR2","unstructured":"A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2\u2014Full Text View\u2014ClinicalTrials.gov. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03203421?term=adenovirus&recrs=a&cond=malaria&rank=2 (accessed 23rd September 2017)."},{"key":"8599_CR3","unstructured":"Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and\/or MVA-BN-Filo\u2014Full Text View\u2014ClinicalTrials.gov. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02661464?term=adenovirus&recrs=a&cond=ebola&rank=1 (accessed 23rd September 2017)."},{"key":"8599_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","volume":"4","author":"CS Lee","year":"2017","unstructured":"Lee, C. S. et al. Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes Dis. 4, 43\u201363 (2017).","journal-title":"Genes Dis."},{"key":"8599_CR5","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1128\/JVI.02696-06","volume":"81","author":"P Abbink","year":"2007","unstructured":"Abbink, P. et al. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 81, 4654\u20134663 (2007).","journal-title":"J. Virol."},{"key":"8599_CR6","doi-asserted-by":"publisher","unstructured":"King, A. M. Q., Adams, M. J., Carstens, E. B. & Lefkowitz, E. J. (eds). Family\u2014Adenoviridae. in Virus Taxonomy 125\u2013141 (Elsevier, 2012). https:\/\/doi.org\/10.1016\/B978-0-12-384684-6.00009-4.","DOI":"10.1016\/B978-0-12-384684-6.00009-4"},{"key":"8599_CR7","unstructured":"International Committee on Taxonomy of Viruses. Virus Taxonomy: Classification and Nomenclature of Viruses: Sixth Report of the International Committee on Taxonomy of Viruses (Springer-Verlag, 1995)."},{"key":"8599_CR8","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","volume":"28","author":"TC Mast","year":"2010","unstructured":"Mast, T. C. et al. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine 28, 950\u2013957 (2010).","journal-title":"Vaccine"},{"key":"8599_CR9","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.3390\/v7112923","volume":"7","author":"H Uusi-Kerttula","year":"2015","unstructured":"Uusi-Kerttula, H., Hulin-Curtis, S., Davies, J. & Parker, A. L. Oncolytic adenovirus: strategies and insights for vector design and immuno-oncolytic applications. Viruses 7, 6009\u20136042 (2015).","journal-title":"Viruses"},{"key":"8599_CR10","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1086\/587993","volume":"46","author":"FH Priddy","year":"2008","unstructured":"Priddy, F. H. et al. Safety and immunogenicity of a replication\u2010incompetent adenovirus type 5 HIV\u20101 Clade B gag\/pol\/nef vaccine in healthy adults. Clin. Infect. Dis. 46, 1769\u20131781 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"8599_CR11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/infdis\/jiu217","volume":"210","author":"LR Baden","year":"2014","unstructured":"Baden, L. R. et al. First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002). J. Infect. Dis. 210, 1052\u20131061 (2014).","journal-title":"J. Infect. Dis."},{"key":"8599_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0140-6736(18)31364-3","volume":"392","author":"DH Barouch","year":"2018","unstructured":"Barouch, D. H. et al. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1\/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). Lancet 392, 232\u2013243 (2018).","journal-title":"Lancet"},{"key":"8599_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep01812","volume":"3","author":"CM Robinson","year":"2013","unstructured":"Robinson, C. M. et al. Molecular evolution of human adenoviruses. Sci. Rep. 3, 1812 (2013).","journal-title":"Sci. Rep."},{"key":"8599_CR14","doi-asserted-by":"publisher","first-page":"9553","DOI":"10.1128\/JVI.77.17.9553-9566.2003","volume":"77","author":"JJ Rux","year":"2003","unstructured":"Rux, J. J., Kuser, P. R. & Burnett, R. M. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods. J. Virol. 77, 9553\u20139566 (2003).","journal-title":"J. Virol."},{"key":"8599_CR15","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1128\/JVI.06969-11","volume":"86","author":"G Singh","year":"2012","unstructured":"Singh, G. et al. Overreliance on the hexon gene, leading to misclassification of human adenoviruses. J. Virol. 86, 4693\u20134695 (2012).","journal-title":"J. Virol."},{"key":"8599_CR16","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1128\/JVI.00740-12","volume":"86","author":"JE Teigler","year":"2012","unstructured":"Teigler, J. E., Iampietro, M. J. & Barouch, D. H. Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in Rhesus monkeys. J. Virol. 86, 9590\u20139598 (2012).","journal-title":"J. Virol."},{"key":"8599_CR17","doi-asserted-by":"publisher","first-page":"10862","DOI":"10.1128\/JVI.00928-12","volume":"86","author":"H Li","year":"2012","unstructured":"Li, H. et al. Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys. J. Virol. 86, 10862\u201310865 (2012).","journal-title":"J. Virol."},{"key":"8599_CR18","doi-asserted-by":"publisher","first-page":"27926","DOI":"10.18632\/oncotarget.8545","volume":"7","author":"H Uusi-Kerttula","year":"2016","unstructured":"Uusi-Kerttula, H. et al. Pseudotyped \u03b1v\u03b26 integrin-targeted adenovirus vectors for ovarian cancer therapies. Oncotarget 7, 27926\u201327937 (2016).","journal-title":"Oncotarget"},{"key":"8599_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1089\/hum.2013.215","volume":"25","author":"ZT Camacho","year":"2014","unstructured":"Camacho, Z. T., Turner, M. A., Barry, M. A. & Weaver, E. A. CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy. Hum. Gene Ther. 25, 364\u2013374 (2014).","journal-title":"Hum. Gene Ther."},{"key":"8599_CR20","doi-asserted-by":"crossref","unstructured":"Weaver, E. A. & Barry, M. A. Low seroprevalent species D adenovirus vectors as influenza vaccines. PLoS ONE 8, e73313 (2013).","DOI":"10.1371\/journal.pone.0073313"},{"key":"8599_CR21","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1128\/JVI.02407-10","volume":"85","author":"TW Geisbert","year":"2011","unstructured":"Geisbert, T. W. et al. Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge. J. Virol. 85, 4222\u20134233 (2011).","journal-title":"J. Virol."},{"key":"8599_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep23014","volume":"6","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Phylogenetic evidence for intratypic recombinant events in a novel human adenovirus C that causes severe acute respiratory infection in children. Sci. Rep. 6, 23014 (2016).","journal-title":"Sci. Rep."},{"key":"8599_CR23","doi-asserted-by":"publisher","first-page":"12635","DOI":"10.1128\/JVI.79.20.12635-12642.2005","volume":"79","author":"K Ebner","year":"2005","unstructured":"Ebner, K., Pinsker, W. & Lion, T. Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications. J. Virol. 79, 12635\u201312642 (2005).","journal-title":"J. Virol."},{"key":"8599_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jmv.23331","volume":"84","author":"YMA Al Qurashi","year":"2012","unstructured":"Al Qurashi, Y. M. A., Alkhalaf, M. A., Lim, L., Guiver, M. & Cooper, R. J. Sequencing and phylogenetic analysis of the hexon, fiber, and penton regions of adenoviruses isolated from AIDS patients. J. Med. Virol. 84, 1157\u20131165 (2012).","journal-title":"J. Med. Virol."},{"key":"8599_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.virol.2008.02.013","volume":"375","author":"L Pache","year":"2008","unstructured":"Pache, L., Venkataraman, S., Nemerow, G. R. & Reddy, V. S. Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses. Virology 375, 573\u2013579 (2008).","journal-title":"Virology"},{"key":"8599_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.003087-0","volume":"90","author":"WC Russell","year":"2009","unstructured":"Russell, W. C. Adenoviruses: update on structure and function. J. Gen. Virol. 90, 1\u201320 (2009).","journal-title":"J. Gen. Virol."},{"key":"8599_CR27","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0969-2126(94)00126-X","volume":"2","author":"D Xia","year":"1994","unstructured":"Xia, D., Henry, L. J., Gerard, R. D. & Deisenhofer, J. Crystal structure of the receptor-binding domain of adenovirus type 5 fiberprotein at 1.7\u2009\u00c5 resolution. Structure 2, 1259\u20131270 (1994).","journal-title":"Structure"},{"key":"8599_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/cancers10060201","volume":"10","author":"AT Baker","year":"2018","unstructured":"Baker, A. T., Aguirre-Hern\u00e1ndez, C., Halld\u00e9n, G. & Parker, A. L. Designer oncolytic adenovirus: coming of age. Cancers 10, 201 (2018).","journal-title":"Cancers"},{"key":"8599_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-91","volume":"10","author":"MC Amoureux","year":"2010","unstructured":"Amoureux, M.-C. et al. Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines. BMC Cancer 10, 91 (2010).","journal-title":"BMC Cancer"},{"key":"8599_CR30","doi-asserted-by":"publisher","first-page":"e1004657","DOI":"10.1371\/journal.ppat.1004657","volume":"11","author":"A Lenman","year":"2015","unstructured":"Lenman, A. et al. Human adenovirus 52 uses sialic acid-containing glycoproteins and the coxsackie and adenovirus receptor for binding to target cells. PLoS Pathog. 11, e1004657 (2015).","journal-title":"PLoS Pathog."},{"key":"8599_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1006\/viro.2002.1503","volume":"302","author":"N Arnberg","year":"2002","unstructured":"Arnberg, N. et al. Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction. Virology 302, 33\u201343 (2002).","journal-title":"Virology"},{"key":"8599_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1128\/JVI.74.1.42-48.2000","volume":"74","author":"N Arnberg","year":"2000","unstructured":"Arnberg, N., Edlund, K., Kidd, A. H. & Wadell, G. Adenovirus type 37 uses sialic acid as a cellular receptor. J. Virol. 74, 42\u201348 (2000).","journal-title":"J. Virol."},{"key":"8599_CR33","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1128\/JVI.01964-09","volume":"84","author":"K Cupelli","year":"2010","unstructured":"Cupelli, K. et al. Structure of adenovirus type 21 knob in complex with CD46 reveals key differences in receptor contacts among species B adenoviruses. J. Virol. 84, 3189\u20133200 (2010).","journal-title":"J. Virol."},{"key":"8599_CR34","doi-asserted-by":"publisher","first-page":"e1001122","DOI":"10.1371\/journal.ppat.1001122","volume":"6","author":"BD Persson","year":"2010","unstructured":"Persson, B. D. et al. Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathog. 6, e1001122 (2010).","journal-title":"PLoS Pathog."},{"key":"8599_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nsmb1190","volume":"14","author":"BD Persson","year":"2007","unstructured":"Persson, B. D. et al. Adenovirus type 11 binding alters the conformation of its receptor CD46. Nat. Struct. Mol. Biol. 14, 164\u2013166 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"8599_CR36","doi-asserted-by":"publisher","first-page":"12785","DOI":"10.1128\/JVI.01732-07","volume":"81","author":"H Wang","year":"2007","unstructured":"Wang, H. et al. Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob. J. Virol. 81, 12785\u201312792 (2007).","journal-title":"J. Virol."},{"key":"8599_CR37","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1128\/JVI.74.6.2804-2813.2000","volume":"74","author":"I Kirby","year":"2000","unstructured":"Kirby, I. et al. Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein. J. Virol. 74, 2804\u20132813 (2000).","journal-title":"J. Virol."},{"key":"8599_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nm.2267","volume":"17","author":"EC Nilsson","year":"2011","unstructured":"Nilsson, E. C. et al. The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat. Med. 17, 105\u2013109 (2011).","journal-title":"Nat. Med."},{"key":"8599_CR39","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1099\/vir.0.83142-0","volume":"88","author":"C Fleischli","year":"2007","unstructured":"Fleischli, C. et al. Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46 receptor. J. Gen. Virol. 88, 2925\u20132934 (2007).","journal-title":"J. Gen. Virol."},{"key":"8599_CR40","doi-asserted-by":"publisher","first-page":"33704","DOI":"10.1074\/jbc.M605316200","volume":"281","author":"E Seiradake","year":"2006","unstructured":"Seiradake, E., Lortat-Jacob, H., Billet, O., Kremer, E. J. & Cusack, S. Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor. J. Biol. Chem. 281, 33704\u201333716 (2006).","journal-title":"J. Biol. Chem."},{"key":"8599_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/prot.10104","volume":"47","author":"E Krieger","year":"2002","unstructured":"Krieger, E., Koraimann, G. & Vriend, G. Increasing the precision of comparative models with YASARA NOVA\u2014a self\u2010parameterizing force field. Proteins Struct. Funct. Bioinformatics 47, 393\u2013402 (2002).","journal-title":"Proteins Struct. Funct. Bioinformatics"},{"key":"8599_CR42","doi-asserted-by":"publisher","first-page":"12441","DOI":"10.1039\/C5CP00628G","volume":"17","author":"JH Jensen","year":"2015","unstructured":"Jensen, J. H. Predicting accurate absolute binding energies in aqueous solution: thermodynamic considerations for electronic structure methods. Phys. Chem. Chem. Phys. 17, 12441\u201312451 (2015).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"8599_CR43","doi-asserted-by":"crossref","unstructured":"Vassal-Stermann, E. et al. Mapping of adenovirus of serotype 3 fibre interaction to desmoglein 2 revealed a novel \u2018non-classical\u2019 mechanism of viral receptor engagement. Sci. Rep. 8, 8381 (2018).","DOI":"10.1038\/s41598-018-26871-x"},{"key":"8599_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nm.2270","volume":"17","author":"H Wang","year":"2011","unstructured":"Wang, H. et al. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat. Med. 17, 96\u2013104 (2011).","journal-title":"Nat. Med."},{"key":"8599_CR45","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1128\/JVI.77.2.1157-1162.2003","volume":"77","author":"A Segerman","year":"2003","unstructured":"Segerman, A., Arnberg, N., Erikson, A., Lindman, K. & Wadell, G. There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses. J. Virol. 77, 1157\u20131162 (2003).","journal-title":"J. Virol."},{"key":"8599_CR46","doi-asserted-by":"publisher","first-page":"e2409","DOI":"10.1371\/journal.pone.0002409","volume":"3","author":"I Kuhn","year":"2008","unstructured":"Kuhn, I. et al. Directed evolution generates a novel oncolytic virus for the treatment of colon cancer. PLoS ONE 3, e2409 (2008).","journal-title":"PLoS One"},{"key":"8599_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.omto.2017.03.003","volume":"5","author":"S Illingworth","year":"2017","unstructured":"Illingworth, S. et al. Preclinical safety studies of enadenotucirev, a chimeric group B human-specific oncolytic adenovirus. Mol. Ther. Oncolytics 5, 62\u201374 (2017).","journal-title":"Mol. Ther. Oncolytics"},{"key":"8599_CR48","unstructured":"HAdV Working Group. http:\/\/hadvwg.gmu.edu\/."},{"key":"8599_CR49","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1128\/JVI.06254-11","volume":"86","author":"RR Bradley","year":"2012","unstructured":"Bradley, R. R., Lynch, D. M., Iampietro, M. J., Borducchi, E. N. & Barouch, D. H. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection. J. Virol. 86, 625\u2013629 (2012).","journal-title":"J. Virol."},{"key":"8599_CR50","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1128\/JVI.06165-11","volume":"86","author":"RR Bradley","year":"2012","unstructured":"Bradley, R. R. et al. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions. J. Virol. 86, 1267\u20131272 (2012).","journal-title":"J. Virol."},{"key":"8599_CR51","doi-asserted-by":"crossref","unstructured":"Ma, J. et al. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo. PLoS Pathog. 11, e1004673 (2015).","DOI":"10.1371\/journal.ppat.1004673"},{"key":"8599_CR52","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1128\/JVI.01878-08","volume":"83","author":"AL Parker","year":"2009","unstructured":"Parker, A. L. et al. Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer. J. Virol. 83, 479\u2013483 (2009).","journal-title":"J. Virol."},{"key":"8599_CR53","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0092-8674(02)00912-1","volume":"110","author":"RW Walters","year":"2002","unstructured":"Walters, R. W. et al. Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 110, 789\u2013799 (2002).","journal-title":"Cell"},{"key":"8599_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15740","volume":"8","author":"BF Keele","year":"2017","unstructured":"Keele, B. F. et al. Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys. Nat. Commun. 8, 15740 (2017).","journal-title":"Nat. Commun."},{"key":"8599_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1469-1809.1985.tb01673.x","volume":"49","author":"PW Andrews","year":"1985","unstructured":"Andrews, P. W. et al. A human cell-surface antigen defined by a monoclonal antibody and controlled by a gene on human chromosome 1. Ann. Hum. Genet. 49, 31\u201339 (1985).","journal-title":"Ann. Hum. Genet."},{"key":"8599_CR56","doi-asserted-by":"publisher","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science 357, eaan2507 (2017).","journal-title":"Science"},{"key":"8599_CR57","doi-asserted-by":"publisher","first-page":"e1000277","DOI":"10.1371\/journal.ppat.1000277","volume":"5","author":"E Seiradake","year":"2009","unstructured":"Seiradake, E. et al. The cell adhesion molecule \u201cCAR\u201d and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog. 5, e1000277 (2009).","journal-title":"PLoS Pathog."},{"key":"8599_CR58","doi-asserted-by":"publisher","first-page":"15191","DOI":"10.1073\/pnas.261452898","volume":"98","author":"CJ Cohen","year":"2001","unstructured":"Cohen, C. J. et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc. Natl. Acad. Sci. USA 98, 15191\u201315196 (2001).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"8599_CR59","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.1128\/JVI.78.12.6431-6438.2004","volume":"78","author":"V Awasthi","year":"2004","unstructured":"Awasthi, V., Meinken, G., Springer, K., Srivastava, S. C. & Freimuth, P. Biodistribution of radioiodinated adenovirus fiber protein knob domain after intravenous injection in mice. J. Virol. 78, 6431\u20136438 (2004).","journal-title":"J. Virol."},{"key":"8599_CR60","doi-asserted-by":"publisher","unstructured":"Lenman, A. et al. Polysialic acid is a cellular receptor for human adenovirus 52. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1716900115 (2018).","DOI":"10.1073\/pnas.1716900115"},{"key":"8599_CR61","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539\u2013539 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"8599_CR62","doi-asserted-by":"publisher","first-page":"W580","DOI":"10.1093\/nar\/gkv279","volume":"43","author":"W Li","year":"2015","unstructured":"Li, W. et al. The EMBL-EBI bioinformatics web and programmatic tools framework. Nucleic Acids Res. 43, W580\u2013W584 (2015).","journal-title":"Nucleic Acids Res."},{"key":"8599_CR63","doi-asserted-by":"publisher","unstructured":"Jukes, T. H. & Cantor, C. R. Evolution of protein molecules. in Mammalian Protein Metabolism 21\u2013132 (Elsevier, 1969). https:\/\/doi.org\/10.1016\/B978-1-4832-3211-9.50009-7.","DOI":"10.1016\/B978-1-4832-3211-9.50009-7"},{"key":"8599_CR64","doi-asserted-by":"publisher","unstructured":"Zuckerkandl, E. & Pauling, L. Evolutionary divergence and convergence in proteins. in Evolving Genes and Proteins (eds Bryson, V. & Vogel, H. J.) 97\u2013166 (Academic Press, 1965). https:\/\/doi.org\/10.1016\/B978-1-4832-2734-4.50017-6.","DOI":"10.1016\/B978-1-4832-2734-4.50017-6"},{"key":"8599_CR65","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","volume":"35","author":"S Kumar","year":"2018","unstructured":"Kumar, S., Stecher, G., Li, M., Knyaz, C. & Tamura, K. MEGA X: Molecular Evolutionary Genetics Analysis across computing platforms. Mol. Biol. Evol. 35, 1547\u20131549 (2018).","journal-title":"Mol. Biol. Evol."},{"key":"8599_CR66","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1558-5646.1985.tb00420.x","volume":"39","author":"J Felsenstein","year":"1985","unstructured":"Felsenstein, J. Confidence limits on phylogenies: an approach using the Bootstrap. Evolution 39, 783\u2013791 (1985).","journal-title":"Evolution"},{"key":"8599_CR67","doi-asserted-by":"publisher","first-page":"W35","DOI":"10.1093\/nar\/gkn211","volume":"36","author":"M Garcia-Boronat","year":"2008","unstructured":"Garcia-Boronat, M., Diez-Rivero, C. M., Reinherz, E. L. & Reche, P. A. PVS: a web server for protein sequence variability analysis tuned to facilitate conserved epitope discovery. Nucleic Acids Res. 36, W35\u2013W41 (2008).","journal-title":"Nucleic Acids Res."},{"key":"8599_CR68","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/hum.2014.016","volume":"25","author":"L Coughlan","year":"2014","unstructured":"Coughlan, L. et al. Retargeting adenovirus serotype 48 fiber knob domain by peptide incorporation. Hum. Gene Ther. 25, 385\u2013394 (2014).","journal-title":"Hum. Gene Ther."},{"key":"8599_CR69","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1128\/JVI.00445-09","volume":"83","author":"L Coughlan","year":"2009","unstructured":"Coughlan, L. et al. In vivo retargeting of adenovirus type 5 to \u03b1v\u03b26 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery. J. Virol. 83, 6416\u20136428 (2009).","journal-title":"J. Virol."},{"key":"8599_CR70","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson, J. M. et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320\u20131323 (1997).","journal-title":"Science"},{"key":"8599_CR71","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1073\/pnas.91.6.2161","volume":"91","author":"M Manchester","year":"1994","unstructured":"Manchester, M., Liszewski, M. K., Atkinson, J. P. & Oldstone, M. B. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc. Natl. Acad. Sci. USA 91, 2161\u20132165 (1994).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"8599_CR72","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1107\/S0907444913015308","volume":"69","author":"G Winter","year":"2013","unstructured":"Winter, G., Lobley, C. M. C. & Prince, S. M. Decision making in xia2. Acta Crystallogr. D Biol. Crystallogr. 69, 1260\u20131273 (2013).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"8599_CR73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","volume":"67","author":"C Vonrhein","year":"2011","unstructured":"Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D Biol. Crystallogr. 67, 293\u2013302 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"8599_CR74","doi-asserted-by":"crossref","unstructured":"Dodson, E. J., Winn, M. & Ralph, A. Collaborative computational project, number 4: providing programs for protein crystallography, Vol. 277. in Methods in Enzymology 620\u2013633 (Academic Press, 1997).","DOI":"10.1016\/S0076-6879(97)77034-4"},{"key":"8599_CR75","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"8599_CR76","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"8599_CR77","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"8599_CR78","unstructured":"Schr\u00f6dinger, LLC. The PyMOL Molecular Graphics System, Version 2.0."},{"key":"8599_CR79","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/prot.22570","volume":"77","author":"E Krieger","year":"2009","unstructured":"Krieger, E. et al. Improving physical realism, stereochemistry, and side\u2010chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins Struct. Funct. Bioinformatics 77, 114\u2013122 (2009).","journal-title":"Proteins Struct. Funct. Bioinformatics"},{"key":"8599_CR80","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08599-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08599-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08599-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T15:10:08Z","timestamp":1671203408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08599-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["8599"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-08599-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/406819","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"741"}}